You are viewing a free limited preview of VentiRx Pharmaceuticals, Inc.
Get Full Access To This Report 
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
VentiRx Pharmaceuticals, Inc. is a privately-held, venture capital backed biopharmaceutical company that engages in the development and commercialization of novel toll-like receptor therapeutics for the treatment of cancer, respiratory, allergy, and autoimmune and inflammatory diseases. Founded in 2006 by Michael J. Kamdar and Robert M. Hershberg, VentiRx Pharmaceuticals is headquartered in San Diego, California with additional operations in Seattle.
| Company Tags: | VC Backed |
| Year Founded: | 2006 |
| Fiscal Year End: | 12/31 |
| City: | San Diego |
| State/Province: | California |
| Country: | United States |
| Phone: | View |
| Website: | www.ventirx.com |
| Founders: | Michael Kamdar |
| Healthcare > Pharmaceuticals > Drug-Related Products |
The PrivCo Industry Classification System™ (PICS) is our proprietary, modernized industry classification system, geared especially toward privately-held companies and including newer emerging sub-industries that are not reflected in other outdated industry classification systems, such as SIC and NAICS.
$99 Single Company AccessInstant Full Site-Wide Access| Date | Investor | Round | Investor Type | |
| Jun. 2008 | View | Other | Venture Capital | |
| Jun. 2008 | View | Other | Venture Capital | |
| Jun. 2008 | View | Other | ||
| Details | Total Round Other View | |||
| Jan. 2010 | View | A | Venture Capital | |
| Jan. 2010 | View | A | Venture Capital | |
| Jan. 2010 | View | A | Venture Capital | |
| Jan. 2010 | View | A | Venture Capital | |
| Details | Total Round A View | |||
| Oct. 2012 | View | Venture Financing | Corporate | |
| Details | Total Round Venture Financing1 View | |||
| Total of Funding Shown Above View | ||||
| 1 | As part of the...Read More → |
Full-length notes are available with Single Report Access or PrivCo Premium Subscription. |
Missing a deal? Tell us about it! tips@privco.com
|
Get Full Access To This Report
| or | Upgrade to PrivCo Premium |
| $99 Single Company Access | Instant Full Site-Wide Access Currently 50% Off Until May. 31! |
PrivCo is the authority for financial & business data on major private companies, including:
| Private Companies | 209,149 |
| Private Investors | 12,004 |
| Private M&A Deals | 43,153 |
| VC/Funding Rounds | 36,088 |
| Total Data Points | 95,786,176 |
You are viewing a free limited preview of VentiRx Pharmaceuticals, Inc.
PrivCo is the premier source for business and financial data on major, non-publicly traded corporations, including family owned, private equity owned, venture backed, and international unlisted companies. Click here to learn more.
PDF VERSION: Download Company Report in PDF Format
EXPORT COMPANY'S DATA TO EXCEL:
Full Online Report